- Home
- TAOP vs RSLS Comparison
TAOP vs RSLS Comparison
Compare TAOP & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- RSLS
- Stock Information
- Founded
- TAOP 1993
- RSLS 2002
- Country
- TAOP China
- RSLS United States
- Employees
- TAOP N/A
- RSLS N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- RSLS Medical/Dental Instruments
- Sector
- TAOP Technology
- RSLS Health Care
- Exchange
- TAOP Nasdaq
- RSLS Nasdaq
- Market Cap
- TAOP 4.8M
- RSLS 5.7M
- IPO Year
- TAOP N/A
- RSLS 2007
- Fundamental
- Price
- TAOP $4.13
- RSLS $2.40
- Analyst Decision
- TAOP
- RSLS
- Analyst Count
- TAOP 0
- RSLS 0
- Target Price
- TAOP N/A
- RSLS N/A
- AVG Volume (30 Days)
- TAOP 27.7K
- RSLS 453.7K
- Earning Date
- TAOP 09-04-2025
- RSLS 08-13-2025
- Dividend Yield
- TAOP N/A
- RSLS N/A
- EPS Growth
- TAOP N/A
- RSLS N/A
- EPS
- TAOP N/A
- RSLS N/A
- Revenue
- TAOP $36,672,512.00
- RSLS $7,175,000.00
- Revenue This Year
- TAOP N/A
- RSLS $52.80
- Revenue Next Year
- TAOP N/A
- RSLS N/A
- P/E Ratio
- TAOP N/A
- RSLS N/A
- Revenue Growth
- TAOP N/A
- RSLS N/A
- 52 Week Low
- TAOP $3.56
- RSLS $2.23
- 52 Week High
- TAOP $29.40
- RSLS $311.46
- Technical
- Relative Strength Index (RSI)
- TAOP 37.83
- RSLS 40.81
- Support Level
- TAOP $4.09
- RSLS $2.85
- Resistance Level
- TAOP $4.51
- RSLS $3.55
- Average True Range (ATR)
- TAOP 0.41
- RSLS 0.29
- MACD
- TAOP 0.03
- RSLS 0.09
- Stochastic Oscillator
- TAOP 33.02
- RSLS 7.26
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.